More answers like this
GPT-5Sep 6, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Short answer: Don’t pause all AI. Do impose targeted, enforceable restrictions—and be willing to pause frontier-scale training or deployment unless clear safety bars are met.
Key distinctions
•Development vs deployment: It’s often wiser to slow or stage deployment while continuing safety research and lower‑risk R&D.
•Blanket pause vs conditional moratoria: Pausing everything is blunt and costly; pausing specific high‑risk activities until safeguards exist is practical.
Why not a blanket pause?
•AI already delivers clear benefits (science, healthcare, accessibility, productivity).
•A total pause is hard to coordinate globally and risks pushing work underground or to less‑regulated jurisdictions.
•It can entrench incumbents and stifle open safety research.
Why targeted restrictions (and occasional pauses) make sense
•Some capabilities can materially enable serious harm (bio design, scalable cyber offense, autonomous replication, sophisticated deception/manipulation).
•Frontier training runs concentrate risk (emergent capabilities, misuse at scale, systemic impacts).
•Precedent from aviation, nuclear, and biomedicine: license the riskiest activities, require safety cases, and stage deployments.
A practical compromise
1)Gate frontier-scale training and release
•Require licensing and pre‑registration for training runs above a compute threshold (e.g., the US already requires reporting above certain FLOP levels).
•Allow training/deployment only after:
•Independent red‑teaming and capability/risk evaluations (bio, cyber, autonomy, persuasion).
•Documented “safety case” showing hazards, mitigations, and residual risk.
•Model security (protect weights), incident response plans, and the ability to rapidly disable or roll back models.
•Stage releases: internal → partners → API with guardrails → wider access; release weights only when evaluations show low misuse risk.
2)Restrict specific dangerous capabilities regardless of model size
•Disallow features or outputs that materially enable novices to perform CBRN harm, high‑severity zero‑day exploitation, or autonomous self‑replication.
•For agentic systems: require strong rate limits, verified user identity for powerful tools, tool/action whitelists, and human‑in‑the‑loop for high‑impact operations.
3)Make providers accountable
•Mandatory risk management systems (e.g., NIST AI RMF/ISO 42001‑style), audit logs, and post‑deployment monitoring for misuse.
•Third‑party audits; liability for negligent deployment that foreseeably causes harm.
•Security baselines for data, training clusters, and model weights; supply‑chain and chip/compute tracking.
4)Transparency proportional to risk
•System/model cards, training data provenance disclosures, evaluations and red‑team results summaries.
•Content provenance and watermarking for AI‑generated media where feasible.
5)Support the “good stuff”
•Exempt or simplify compliance for low‑risk, open, and safety research.
•Fund alignment/safety methods, evaluations, and defensive applications (e.g., bio and cyber defense).
•Encourage privacy‑preserving techniques and energy‑efficient training.
6)International coordination
•Align on thresholds, evaluations, and incident reporting.
•Close regulatory arbitrage via export controls on the riskiest chips/compute and cloud KYC for large training runs.
•Share safety research and best practices.
When to actually pause
•If a model fails independent dangerous‑capability evaluations or mitigations are not credible.
•If monitoring shows escalating real‑world misuse.
•If capabilities are advancing faster than governance capacity—pause the next scaling step while building the missing safeguards.
Bottom line: Keep beneficial AI work moving, but place binding brakes on frontier scaling and clearly dangerous capabilities. Use conditional, verifiable pauses as a tool—not the default—and tie them to concrete safety criteria, audits, and staged deployment.